Kyle Jenne - Net Worth and Insider Trading
Kyle Jenne Net Worth
The estimated net worth of Kyle Jenne is at least $945,058 dollars as of 2024-12-29. Kyle Jenne is the Chief Commercial Officer of Akcea Therapeutics Inc and owns about 52,012 shares of Akcea Therapeutics Inc (AKCA) stock worth over $945,058. Details can be seen in Kyle Jenne's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kyle Jenne has not made any transactions after 2020-09-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kyle Jenne
Kyle Jenne Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kyle Jenne owns 1 companies in total, including Akcea Therapeutics Inc (AKCA) .
Click here to see the complete history of Kyle Jenne’s form 4 insider trades.
Insider Ownership Summary of Kyle Jenne
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKCA | Akcea Therapeutics Inc | 2020-10-12 | Chief Commercial Officer |
Kyle Jenne Latest Holdings Summary
Kyle Jenne currently owns a total of 1 stock. Kyle Jenne owns 52,012 shares of Akcea Therapeutics Inc (AKCA) as of September 22, 2020, with a value of $945,058.
Latest Holdings of Kyle Jenne
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKCA | Akcea Therapeutics Inc | 2020-09-22 | 52,012 | 18.17 | 945,058 |
Holding Weightings of Kyle Jenne
Kyle Jenne Form 4 Trading Tracker
According to the SEC Form 4 filings, Kyle Jenne has made a total of 2 transactions in Akcea Therapeutics Inc (AKCA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Akcea Therapeutics Inc is the sale of 720 shares on September 22, 2020, which brought Kyle Jenne around $13,046.
Insider Trading History of Kyle Jenne
- 1
Kyle Jenne Trading Performance
Kyle Jenne Ownership Network
Kyle Jenne Owned Company Details
What does Akcea Therapeutics Inc do?
Who are the key executives at Akcea Therapeutics Inc?
Kyle Jenne is the Chief Commercial Officer of Akcea Therapeutics Inc. Other key executives at Akcea Therapeutics Inc include director & Chief Executive Officer Damien Mcdevitt , Chief Medical Officer William T. Andrews , and Chief Financial Officer Michael Dennis Price .
Akcea Therapeutics Inc (AKCA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akcea Therapeutics Inc (AKCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akcea Therapeutics Inc (AKCA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akcea Therapeutics Inc (AKCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akcea Therapeutics Inc Insider Transactions
Kyle Jenne Mailing Address
Above is the net worth, insider trading, and ownership report for Kyle Jenne. You might contact Kyle Jenne via mailing address: C/o Akcea Therapeutics, Inc. 22 Boston Wharf Road, 9th Floor Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
